Your browser doesn't support javascript.
loading
2-Geranyl-1-methoxyerythrabyssin II alleviates lipid accumulation and inflammation in hepatocytes through AMPK activation and AKT inhibition.
Xi, Yiyuan; Kim, Soeun; Nguyen, Thi Thanh Thuy; Lee, Phil Jun; Zheng, Jujia; Lin, Zhuofeng; Cho, Namki.
Affiliation
  • Xi Y; The Clinical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
  • Kim S; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju, 61186, Korea.
  • Nguyen TTT; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Lee PJ; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju, 61186, Korea.
  • Zheng J; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju, 61186, Korea.
  • Lin Z; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju, 61186, Korea.
  • Cho N; The Clinical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
Arch Pharm Res ; 46(9-10): 808-824, 2023 Oct.
Article in En | MEDLINE | ID: mdl-37782374

Full text: 1 Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease Limits: Animals / Child / Humans Language: En Journal: Arch Pharm Res Year: 2023 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease Limits: Animals / Child / Humans Language: En Journal: Arch Pharm Res Year: 2023 Type: Article Affiliation country: China